LoadingLoadingLoadingThe quick read
Latest quote·Oct 12
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. CVS Health Corp (CVS) insiders filed no open-market purchases or sales in the 90 days to Oct 16, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a CVS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 16, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (3)
Viking Global
$379.0M
bought
Millennium
$210.0M
added
Bank of America
$1.7B
added
Sells (2)
Robbins Larry
$317.5M
sold
Mandadi Tilak
$6.2M
sold
Buys (1)
Sells (1)
No tracked top-trader positions in CVS right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Financial period
Q2 2026
Adjusted EPS
$1.85 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $2.58 / $1.85Yahoo Finance | +39.36% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 6, 2026 | $2.57 / $2.21Yahoo Finance | +16.48% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 10, 2026 | $1.09 / $1.00Yahoo Finance | +9.38% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | $1.60 / $1.36Yahoo Finance | +17.93% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $1.81 / $1.46Alpha Vantage | +23.97% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $2.25 / $1.67Alpha Vantage | +34.73% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | $1.19 / $0.92Alpha Vantage | +29.35% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 6, 2024 | $1.09 / $1.46Alpha Vantage | -25.34% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 15, 2026
EPS expected
$1.52 to $1.80
Revenue expected
18 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $102.87B | $105.69B | $100.43B | $106.10B |
| Cost of what it sold | $89.06B | $92.13B | $84.80B | $90.35B |
| Gross profit | $13.81B | $13.57B | $15.62B | $15.75B |
| What it spent | ||||
| Other operating costs | $17.01B | $11.46B | $10.94B | $11.05B |
| Total operating expenses | $17.01B | $11.46B | $10.94B | $11.05B |
| What was left | ||||
| Operating profit | -$3.21B | $2.11B | $4.68B | $4.70B |
| Interest on debt | $784.0M | $787.0M | $774.0M | $757.0M |
| Profit before tax | -$3.48B | $1.35B | $3.94B | $3.98B |
| Tax | $508.0M | -$1.57B | $995.0M | $982.0M |
| Net profit | -$3.98B | $2.94B | $2.94B | $3.00B |
| EBITDA | -$1.56B | $3.29B | $5.83B | $5.86B |
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
Leans bullishOct 15Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
Leans bullishOct 15CVS Health collaborates with The Midlife Collective to redefine a woman’s midlife health journey
BullishOct 1575 million U.S. women are in the years around menopause. CVS will study midlife health.
Leans bullishOct 15CVS Health - Early Detection Matters: Finding Heart Health Risks Earlier
BullishOct 15Eli Lilly’s Retatrutide Lawsuits: What Pharmacies, Telemedicine Companies and Online Retailers Need to Know
NeutralOct 15CVS Health Corporation $CVS Shares Sold by Fort Washington Investment Advisors Inc. OH
NeutralOct 15Leerink cuts CVS Health target to USD 112: CVS Health stock gains 1.47 percent
NeutralOct 15